SCHEMBL31026618

SCHEMBL31026618

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)O)[C@@H](C)O

nearest known ligand 0.49

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ NTSR1 P30989 9/20 0.49
▸ NTSR2 O95665 8/20 0.49
▸ CALCRL Q16602 2/20 0.48
▸ MAPK8 P45983 1/20 0.47
▸ MAPK9 P45984 1/20 0.47
▸ MAPK10 P53779 1/20 0.47
▸ SORT1 Q99523 6/20 0.46
▸ CAPN1 P07384 2/20 0.45
▸ REN P00797 1/20 0.45
▸ BACE1 P56817 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31183007 0.89 CAPN1 (0.51) NTSR1NTSR2CALCRLCAPN1BACE1
SCHEMBL31410876 0.87 CALCRL (0.49) NTSR1NTSR2CALCRLCAPN1BACE1
SCHEMBL8937022 0.87 CAPN1 (0.49) NTSR1NTSR2CALCRLSORT1CAPN1
SCHEMBL8937016 0.87 CAPN1 (0.49) NTSR1NTSR2CALCRLSORT1CAPN1
SCHEMBL31026619 0.87 CAPN1 (0.52) NTSR1NTSR2CALCRLCAPN1
SCHEMBL30603414 0.85 XIAP (0.52) NTSR1NTSR2SORT1REN
SCHEMBL30525421 0.85 CAPN1 (0.50) NTSR1NTSR2SORT1CAPN1
SCHEMBL31235878 0.85 NTSR1 (0.48) NTSR1NTSR2SORT1
SCHEMBL29883331 0.84 XIAP (0.49) NTSR1NTSR2CALCRLMAPK8MAPK9
SCHEMBL31688339 0.84 CAPN1 (0.51) NTSR1NTSR2CALCRLSORT1CAPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025171454-A1 USE OF ORALLY ACTIVE PEPTIDE AND METHOD FOR MODULATING SLEEP PROTEIMAX BIO TECHNOLOGY ISRAEL LTD (IL) 2025-08-21 — — WO disclosed
WO-2024168411-A1 FOOD ADDITIVE AND/OR FOOD SUPPLEMENT, PRODUCTION METHOD, FORMULATION OF FUNCTIONAL FOOD AND/OR FOOD SUPPLEMENT, USE PROTEIMAX BIO TECHNOLOGY ISRAEL LTD (IL) 2024-08-22 — — WO disclosed
WO-2024168411-A1 FOOD ADDITIVE AND/OR FOOD SUPPLEMENT, PRODUCTION METHOD, FORMULATION OF FUNCTIONAL FOOD AND/OR FOOD SUPPLEMENT, USE PROTEIMAX BIO TECHNOLOGY ISRAEL LTD (IL) 2024-08-22 — — WO disclosed
Send feedback